Literature DB >> 2984574

Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator.

R H Weisbart, D W Golde, S C Clark, G G Wong, J C Gasson.   

Abstract

The polymorphonuclear leukocyte (PMN), or neutrophil, is the major host defence cell protecting the body against invasion by bacteria and fungi. Products of oxidative metabolism mediate PMN microbicidal and tumoricidal activity but the mechanisms by which these pathways become activated are not well understood. We have previously described a human granulocyte-macrophage colony-stimulating factor (GM-CSF) of relative molecular mass (Mr) 22,000 that also inhibits neutrophil motility (NIF-T activity). Because of its direct action on granulocytes, this lymphokine is a candidate for a neutrophil-activating factor. We have studied the effect of GM-CSF/NIF-T on superoxide anion generation in response to the bacterial chemo-attractant N-formylmethionyl-leucylphenylalanine (f-MLP), and report here that PMNs preincubated with either purified natural GM-CSF or biosynthetic (recombinant) GM-CSF showed increased (as much as fourfold) superoxide anion production in response to f-MLP. These results indicate that human GM-CSF is a neutrophil-activating factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984574     DOI: 10.1038/314361a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  116 in total

1.  Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

Authors:  F Stephen Hodi; Sandra Lee; David F McDermott; Uma N Rao; Lisa H Butterfield; Ahmad A Tarhini; Philip Leming; Igor Puzanov; Donghoon Shin; John M Kirkwood
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Mononuclear cells from HIV-infected patients produce factors which enhance functional activity of polymorphonuclear neutrophils from healthy subjects.

Authors:  D I Gabrilovich; G K Shepeleva; L V Serebrovskaya; L A Avdeeva; Z K Suvorova; I M Rosly; V K Oganezov; M Z Saidov; A V Panyutich; V V Pokrovsky
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Effect of intramammary infusion of rbGM-CSF on SCC and expression of polymorphonuclear neutrophil adhesion molecules in subclinical mastitis cows.

Authors:  Tomomi Ozawa; Yoshio Kiku; Megumi Mizuno; Shigeki Inumaru; Shiro Kushibiki; Hiroyuki Shingu; Tomoko Matsubara; Hideyuki Takahashi; Tomohito Hayashi
Journal:  Vet Res Commun       Date:  2011-11-05       Impact factor: 2.459

Review 4.  Mechanism of GM-CSF stimulation of neutrophils.

Authors:  R G Coffey
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 5.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

Review 6.  Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results.

Authors:  E Liehl; J Hildebrandt; C Lam; P Mayer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

7.  The detection and initial characterization of colony-stimulating factors in synovial fluid.

Authors:  D J Williamson; C G Begley; M A Vadas; D Metcalf
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  Staphylococcus aureus-stimulated mononuclear leucocyte-conditioned medium increases the neutrophil bactericidal activity, and augments oxygen radical production and degranulation in response to the bacteria.

Authors:  A Ferrante; D P Harvey; E J Bates
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

9.  Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides.

Authors:  C Elbim; S Bailly; S Chollet-Martin; J Hakim; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.